Market research
4582.TSE SymBio Pharmaceuticals Limited
TSE JPY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 4B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.55
Community
Investor discussion
1 comment
Sign in to join the 4582.TSE discussion.
5 years, 6 months ago
SymBio Pharmaceuticals Limited is currently in a long term uptrend where the price is trading 92.4% above its 200 day moving average.
From a valuation standpoint, the stock is 78.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 15.1.
SymBio Pharmaceuticals Limited's total revenue sank by 21.1% to $654M since the same quarter in the previous year.
Its net income has dropped by 89.7% to $-1B since the same quarter in the previous year.
Based on the above factors, SymBio Pharmaceuticals Limited gets an overall score of 2/5.